CLOs on the Move

Gift of Hope

www.giftofhope.org

 
Gift of Hope Organ & Tissue Donor Network is a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana. As one of 58 OPOs that make up the nation’s donation system, we work with 180 hospitals and serve 12 million people in our donation service area. Since 1986, we have saved the lives of more than 23,000 organ transplant recipients and improved the lives of hundreds of thousands of tissue transplant recipients through our efforts.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Holy Redeemer Health System

Holy Redeemer Health System is committed to our mission to care, comfort and heal, and to providing excellent healthcare services to our community.

Healthlink

HealthLink Innovations is a company that provides personalized home health care solutions to improve the patient and their familys quality of life.

HCI Hospital TV

HCI Hospital TV is a Loveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Westside Natural Health Clinic

Westside Natural Health Clinic is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III